Leukocyte infiltration into inflammatory or injured tissues requires a
variety of cell-associated and soluble factors that mediate the commu
nications between circulating leukocytes and vascular cells. During th
e past decade, a superfamily of polypeptide leukocyte chemoattractants
known as chemokines has been identified and demonstrated to selective
ly induce rapid endothelial cell adhesion and transmigration of leukoc
yte subpopulations. Chemokines are produced by virtually every mammali
an somatic cell type in response to inflammatory and immunologic stimu
li and have been detected in tissues of numerous disease states charac
terized by infiltration of distinct leukocyte subsets. Chemokines bind
and activate cell surface receptors that belong to the seven transmem
brane, G protein-coupled receptor superfamily. Several chemokine recep
tors have been identified as fusion cofactors for human immunodeficien
cy virus type 1 (HIV-1). Chemokines have also been shown to play a cri
tical role in atherosclerosis and ischemic reperfusion injury. As chem
okine research is a rapidly expanding area, it is the purpose of this
brief review to summarize recent progress in the field and to focus on
the involvement of chemokines in cardiovascular diseases. Published 1
998, Elsevier Science Inc.